GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 701 filers reported holding GLAXOSMITHKLINE PLC in Q3 2014. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $2,272,000 | -4.0% | 58,994 | +7.5% | 0.07% | -8.6% |
Q3 2016 | $2,367,000 | +8.1% | 54,883 | +8.6% | 0.08% | +2.5% |
Q2 2016 | $2,190,000 | +8.6% | 50,534 | +1.6% | 0.08% | -7.1% |
Q1 2016 | $2,016,000 | +17.1% | 49,726 | +16.6% | 0.08% | +9.0% |
Q4 2015 | $1,721,000 | +39.9% | 42,649 | +33.3% | 0.08% | -18.8% |
Q3 2015 | $1,230,000 | -10.6% | 31,999 | -3.2% | 0.10% | -2.0% |
Q2 2015 | $1,376,000 | +2.4% | 33,040 | +13.5% | 0.10% | +4.3% |
Q1 2015 | $1,344,000 | +40.0% | 29,112 | +29.6% | 0.09% | -9.6% |
Q4 2014 | $960,000 | +33.3% | 22,463 | +43.4% | 0.10% | +19.5% |
Q3 2014 | $720,000 | +51.3% | 15,662 | +76.0% | 0.09% | +35.9% |
Q2 2014 | $476,000 | -27.4% | 8,900 | -27.5% | 0.06% | +33.3% |
Q1 2014 | $656,000 | +101.2% | 12,284 | +101.3% | 0.05% | -4.0% |
Q4 2013 | $326,000 | +74.3% | 6,101 | +62.9% | 0.05% | +31.6% |
Q2 2013 | $187,000 | – | 3,745 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |